Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greenbaum

Showing results (141-150 of 225) with videos related to

Pageof 23
Sort By:
Diabetes|April 16, 2020
Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01David Arribas-Layton, Perrin Guyer, Thomas Delong, et al.
Communications Biology|September 27, 2023
Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetesJeremy R B Newman, S Alice Long, Cate Speake, et al.
Diabetes|July 19, 2013
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participantsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
Diabetes|January 17, 2014
Low HERV-K(C4) copy number is associated with type 1 diabetesMike J Mason, Cate Speake, Vivian H Gersuk, et al.
Diabetologia|June 6, 2020
Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetesKameron B Rodrigues, Matthew J Dufort, Alba Llibre, et al.
Science Translational Medicine|March 4, 2021
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individualsEmily K Sims, Brian N Bundy, Kenneth Stier, et al.
Pediatric Diabetes|June 5, 2010
A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participantsJay M Sosenko, Jeffrey Mahon, Lisa Rafkin, et al.
Clinical and Experimental Immunology|April 23, 2013
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetesJ B Bollyky, S A Long, M Fitch, et al.
Frontiers in Immunology|August 1, 2022
IL-6-Driven pSTAT1 Response Is Linked to T Cell Features Implicated in Early Immune DysregulationKatharina Lambert, Kirsten E Diggins, Britta E Jones, et al.
Clinical Chemistry|April 19, 2008
Standardization of C-peptide measurementsRandie R Little, Curt L Rohlfing, Alethea L Tennill, et al.
Pageof 23

Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
Diabetes|April 16, 2020
Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01David Arribas-Layton, Perrin Guyer, Thomas Delong, et al.
Communications Biology|September 27, 2023
Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetesJeremy R B Newman, S Alice Long, Cate Speake, et al.
Diabetes|July 19, 2013
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participantsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
Diabetes|January 17, 2014
Low HERV-K(C4) copy number is associated with type 1 diabetesMike J Mason, Cate Speake, Vivian H Gersuk, et al.
Diabetologia|June 6, 2020
Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetesKameron B Rodrigues, Matthew J Dufort, Alba Llibre, et al.
Science Translational Medicine|March 4, 2021
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individualsEmily K Sims, Brian N Bundy, Kenneth Stier, et al.
Pediatric Diabetes|June 5, 2010
A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participantsJay M Sosenko, Jeffrey Mahon, Lisa Rafkin, et al.
Clinical and Experimental Immunology|April 23, 2013
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetesJ B Bollyky, S A Long, M Fitch, et al.
Frontiers in Immunology|August 1, 2022
IL-6-Driven pSTAT1 Response Is Linked to T Cell Features Implicated in Early Immune DysregulationKatharina Lambert, Kirsten E Diggins, Britta E Jones, et al.
Clinical Chemistry|April 19, 2008
Standardization of C-peptide measurementsRandie R Little, Curt L Rohlfing, Alethea L Tennill, et al.
Pageof 23